Cargando…

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay

The intestinal microbiota represents the microbial community that colonizes the gastrointestinal tract and constitutes the most complex ecosystem present in nature. The main intestinal microbial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucromicrobia,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abenavoli, Ludovico, Giubilei, Lidia, Procopio, Anna Caterina, Spagnuolo, Rocco, Luzza, Francesco, Boccuto, Luigi, Scarpellini, Emidio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785319/ https://www.ncbi.nlm.nih.gov/pubmed/36558483 http://dx.doi.org/10.3390/nu14245323

Ejemplares similares

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Fecal Microbiota Transplantation in NAFLD Treatment
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey
por: Spagnuolo, Rocco, et al.
Publicado: (2020)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms
por: Boccuto, Luigi, et al.
Publicado: (2023)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
por: Tkach, Sergii, et al.
Publicado: (2022)

The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study
por: Larussa, Tiziana, et al.
Publicado: (2020)

Nutritional Support in Acute Liver Failure
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series
por: Larussa, Tiziana, et al.
Publicado: (2021)

Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
por: Scarpellini, Emidio, et al.
Publicado: (2020)

Gut Microbiota and Obesity: A Role for Probiotics
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
por: Abenavoli, Ludovico, et al.
Publicado: (2017)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study
por: Tallarico, Martina, et al.
Publicado: (2022)

The Skin in Celiac Disease Patients: The Other Side of the Coin
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization
por: Larussa, Tiziana, et al.
Publicado: (2019)

The Legacy of Renato Dulbecco in the Post-Genomic Era
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
por: Mori, Hideki, et al.
Publicado: (2022)

Race: How the Post-Genomic Era Has Unmasked a Misconception Promoted by Healthcare
por: Schaare, Donna, et al.
Publicado: (2023)

Bone Mineralization in Celiac Disease
por: Larussa, Tiziana, et al.
Publicado: (2012)

Pancreatic Cancer and the Family Connection: The Role of Advanced Practitioners in Screening and Educating Genetically At-Risk Individuals
por: Lowe, Tracy, et al.
Publicado: (2023)

Effect of Whey Proteins on Malnutrition and Extubating Time of Critically Ill COVID-19 Patients
por: Scarcella, Marialaura, et al.
Publicado: (2022)

Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey
por: Larussa, Tiziana, et al.
Publicado: (2019)

Familial pancreatic cancer: a case study and review of the psychosocial effects of diagnoses on families
por: Lowe, Tracy, et al.
Publicado: (2023)

Gut Microbiota According to the Metabolome
por: Scarpellini, Emidio, et al.
Publicado: (2023)

T.04.10 EFFECT OF WHEY PROTEINS ON MALNUTRITION AND EXTUBATING TIME OF CRITICALLY ILL COVID-19 PATIENTS
por: Fabiano, G., et al.
Publicado: (2022)

Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial
por: Tkach, Sergii, et al.
Publicado: (2023)

From Pre- and Probiotics to Post-Biotics: A Narrative Review †
por: Scarpellini, Emidio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nv25a9rgjqlg5308577kks7v82